tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NSPR Stock Latest News

InspireMD Secures Funds to Expand Healthcare Innovations
Company AnnouncementsInspireMD Secures Funds to Expand Healthcare Innovations
16d ago
8K
NSPR
InspireMD announce full exercise of warrant tranche for $17.9M in proceeds
PremiumThe Fly
InspireMD announce full exercise of warrant tranche for $17.9M in proceeds
16d ago
NSPR
InspireMD management to meet with Piper Sandler
PremiumThe Fly
InspireMD management to meet with Piper Sandler
1M ago
NSPR
InspireMD Unveils Updated Investor Presentation Online
PremiumCompany Announcements
InspireMD Unveils Updated Investor Presentation Online
1M ago
8K
NSPR
InspireMD’s CGuard Stent Shows Promise in C-GUARDIANS Trial
PremiumCompany Announcements
InspireMD’s CGuard Stent Shows Promise in C-GUARDIANS Trial
2M ago
8K
NSPR
InspireMD presents one-year follow-up results from C-GUARDIANS IDE trial
PremiumThe FlyInspireMD presents one-year follow-up results from C-GUARDIANS IDE trial
2M ago
NSPR
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024  
PremiumPress Releases
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024  
2M ago
NSPR
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
2M ago
NSPR
InspireMD reports Q1 EPS (21c) vs (53c) last year
PremiumThe Fly
InspireMD reports Q1 EPS (21c) vs (53c) last year
2M ago
NSPR
NSPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
NSPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
NSPR
InspireMD Boosts Executive Severance Benefits Ahead of Potential Takeover
PremiumCompany Announcements
InspireMD Boosts Executive Severance Benefits Ahead of Potential Takeover
4M ago
8K
NSPR
InspireMD to Present Key Trial Results at LINC 2024
PremiumCompany Announcements
InspireMD to Present Key Trial Results at LINC 2024
4M ago
8K
NSPR
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
PremiumPress ReleasesInspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
4M ago
NSPR
InspireMD announces abstract one-year follow-up results from C-GUARDIANS trial
PremiumThe Fly
InspireMD announces abstract one-year follow-up results from C-GUARDIANS trial
4M ago
NSPR
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
4M ago
NSPR
InspireMD reports Q4 EPS (16c) vs (60c) last year
PremiumThe Fly
InspireMD reports Q4 EPS (16c) vs (60c) last year
4M ago
NSPR
NSPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
NSPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
NSPR
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System
PremiumPress Releases
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System
5M ago
NSPR
InspireMD appoints principal investigators for C-GUARDIANS II clinical trial
PremiumThe Fly
InspireMD appoints principal investigators for C-GUARDIANS II clinical trial
5M ago
NSPR
InspireMD Secures CE Mark Recertification Under New EU Standards
PremiumCompany AnnouncementsInspireMD Secures CE Mark Recertification Under New EU Standards
6M ago
8K
NSPR
InspireMD Announces CE Mark Recertification Under MDR
PremiumCompany Announcements
InspireMD Announces CE Mark Recertification Under MDR
6M ago
8K
NSPR
InspireMD receives CE Mark recertification under E.U.’s new MDR framework
PremiumThe Fly
InspireMD receives CE Mark recertification under E.U.’s new MDR framework
6M ago
NSPR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >